For: | Villéger R, Lopès A, Veziant J, Gagnière J, Barnich N, Billard E, Boucher D, Bonnet M. Microbial markers in colorectal cancer detection and/or prognosis. World J Gastroenterol 2018; 24(22): 2327-2347 [PMID: 29904241 DOI: 10.3748/wjg.v24.i22.2327] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v24/i22/2327.htm |
Number | Citing Articles |
1 |
Xu-Qin Xie, Mo-Jin Wang, Yuan Li, Lin-Ping Lei, Ning Wang, Zhao-Ying Lv, Ke-Ling Chen, Bin Zhou, Jie Ping, Zong-Guang Zhou, Xiao-Feng Sun. miR-124 Intensified Oxaliplatin-Based Chemotherapy by Targeting CAPN2 in Colorectal Cancer. Molecular Therapy - Oncolytics 2020; 17: 320 doi: 10.1016/j.omto.2020.04.003
|
2 |
Velda J. González-Mercado, Josué Pérez-Santiago, Debra Lyon, Israel Dilán-Pantojas, Wendy Henderson, Susan McMillan, Maureen Groer, Brad Kane, Sara Marrero, Elsa Pedro, Leorey N. Saligan. The Role of Gut Microbiome Perturbation in Fatigue Induced by Repeated Stress from Chemoradiotherapy: A Proof of Concept Study. Advances in Medicine 2020; 2020: 1 doi: 10.1155/2020/6375876
|
3 |
Xuhua Wang, Zhaoyuan Chen, Huaqiang Zhou, Wuyang Liu, Jiaquan Luo. LncRNA LOXL1-AS1 expression in cancer prognosis: A meta-analysis. Medicine 2022; 101(52): e32436 doi: 10.1097/MD.0000000000032436
|
4 |
Lena Völlger, Thomas Ulas, Sabine Pirr, Anna S. Heinemann, Thomas Vogl, Julia Pagel, Maike Willers, Olga Halle, Sabine Schreek, Jennifer Schöning, Oksana Salwasser, Yi Yu, Beate Fehlhaber, Peter Hombach, Simon Graspeuntner, Katja Cloppenborg-Schmidt, Sven Künzel, Danny Jonigk, Jan Rupp, Gesine Hansen, Reinhold Förster, John F. Baines, Christoph Härtel, Joachim L. Schultze, Johannes Roth, Dorothee Viemann. S100-Alarmins are Crucial Host Factors for the Postnatal Development of Gut Homeostasis. SSRN Electronic Journal 2019; doi: 10.2139/ssrn.3382548
|
5 |
Yiwen Cheng, Zongxin Ling, Lanjuan Li. The Intestinal Microbiota and Colorectal Cancer. Frontiers in Immunology 2020; 11 doi: 10.3389/fimmu.2020.615056
|
6 |
Jinhua He, Feifeng Wu, Zeping Han, Min Hu, Weida Lin, Yuguang Li, Mingrong Cao. Biomarkers (mRNAs and Non-Coding RNAs) for the Diagnosis and Prognosis of Colorectal Cancer – From the Body Fluid to Tissue Level. Frontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.632834
|
7 |
Julie Veziant, Karine Poirot, Caroline Chevarin, Lucie Cassagnes, Pierre Sauvanet, Benoit Chassaing, Frederic Robin, Catherine Godfraind, Nicolas Barnich, Denis Pezet, Bruno Pereira, Johan Gagniere, Mathilde Bonnet. Prognostic value of a combination of innovative factors (gut microbiota, sarcopenia, obesity, metabolic syndrome) to predict surgical/oncologic outcomes following surgery for sporadic colorectal cancer: a prospective cohort study protocol (METABIOTE). BMJ Open 2020; 10(1): e031472 doi: 10.1136/bmjopen-2019-031472
|
8 |
Wenjie Zhang, Jie Zhang, Tian Liu, Juan Xing, Huan Zhang, Daorong Wang, Dong Tang. Bidirectional effects of intestinal microbiota and antibiotics: a new strategy for colorectal cancer treatment and prevention. Journal of Cancer Research and Clinical Oncology 2022; 148(9): 2387 doi: 10.1007/s00432-022-04081-3
|
9 |
Daniel Swafford, Arulkumaran Shanmugam, Punithavathi Ranganathan, Indumathi Manoharan, Mohamed S. Hussein, Nikhil Patel, Humberto Sifuentes, Pandelakis A. Koni, Puttur D. Prasad, Muthusamy Thangaraju, Santhakumar Manicassamy. The Wnt–β-Catenin–IL-10 Signaling Axis in Intestinal APCs Protects Mice from Colitis-Associated Colon Cancer in Response to Gut Microbiota. The Journal of Immunology 2020; 205(8): 2265 doi: 10.4049/jimmunol.1901376
|
10 |
Bruna Cristina dos Santos Cruz, Lisiane Lopes da Conceição, Tiago Antônio de Oliveira Mendes, Célia Lúcia de Luces Fortes Ferreira, Reggiani Vilela Gonçalves, Maria do Carmo Gouveia Peluzio. Use of the synbiotic VSL#3 and yacon-based concentrate attenuates intestinal damage and reduces the abundance of Candidatus Saccharimonas in a colitis-associated carcinogenesis model. Food Research International 2020; 137: 109721 doi: 10.1016/j.foodres.2020.109721
|
11 |
Tomasz Sawicki, Monika Ruszkowska, Anna Danielewicz, Ewa Niedźwiedzka, Tomasz Arłukowicz, Katarzyna E. Przybyłowicz. A Review of Colorectal Cancer in Terms of Epidemiology, Risk Factors, Development, Symptoms and Diagnosis. Cancers 2021; 13(9): 2025 doi: 10.3390/cancers13092025
|
12 |
Vinícius da Silva Duarte, Bruna Cristina dos Santos Cruz, Armin Tarrah, Roberto Sousa Dias, Luiza de Paula Dias Moreira, Wilson José Fernandes Lemos Junior, Lívia Carneiro Fidélis Silva, Gabriele Rocha Santana, Leandro Licursi de Oliveira, Maria do Carmo Gouveia Peluzio, Hilario Cuquetto Mantovani, Viviana Corich, Alessio Giacomini, Sérgio Oliveira de Paula. Chemoprevention of DMH-Induced Early Colon Carcinogenesis in Male BALB/c Mice by Administration of Lactobacillus Paracasei DTA81. Microorganisms 2020; 8(12): 1994 doi: 10.3390/microorganisms8121994
|
13 |
Federica Perillo, Chiara Amoroso, Francesco Strati, Maria Rita Giuffrè, Angélica Díaz-Basabe, Georgia Lattanzi, Federica Facciotti. Gut Microbiota Manipulation as a Tool for Colorectal Cancer Management: Recent Advances in Its Use for Therapeutic Purposes. International Journal of Molecular Sciences 2020; 21(15): 5389 doi: 10.3390/ijms21155389
|
14 |
Nicol Strakova, Kristyna Korena, Renata Karpiskova. Klebsiella pneumoniae producing bacterial toxin colibactin as a risk of colorectal cancer development - A systematic review. Toxicon 2021; 197: 126 doi: 10.1016/j.toxicon.2021.04.007
|
15 |
Jian Wang, Yi Dong, Dong Shang. Rectum adenocarcinoma metabolic subtypes analysis and a risk prognostic model construction based on fatty acid metabolism genes. Medicine 2023; 102(11): e33186 doi: 10.1097/MD.0000000000033186
|
16 |
Rohini Singh, Chandra Shekhar Kumar, Manidipa Banerjee, Shalini Gupta. A Dual Drug Delivery Platform for Cancer–Bacteria Cotargeting. ACS Applied Bio Materials 2019; 2(11): 5032 doi: 10.1021/acsabm.9b00724
|
17 |
Piotr Pęczek, Monika Gajda, Kacper Rutkowski, Marta Fudalej, Andrzej Deptała, Anna M. Badowska-Kozakiewicz. Cancer-associated inflammation: pathophysiology and clinical significance. Journal of Cancer Research and Clinical Oncology 2023; 149(6): 2657 doi: 10.1007/s00432-022-04399-y
|
18 |
Habiba Tariq, Zobia Noreen, Aftab Ahmad, Laraib Khan, Mashhood Ali, Muhammad Malik, Aneela Javed, Faisal Rasheed, Alina Fatima, Tanil Kocagoz, Ugur Sezerman, Habib Bokhari, Grzegorz Woźniakowski. Colibactin possessing E. coli isolates in association with colorectal cancer and their genetic diversity among Pakistani population. PLOS ONE 2022; 17(11): e0262662 doi: 10.1371/journal.pone.0262662
|
19 |
Annemieke Smet, Juozas Kupcinskas, Alexander Link, Georgina L. Hold, Jan Bornschein. The Role of Microbiota in Gastrointestinal Cancer and Cancer Treatment: Chance or Curse?. Cellular and Molecular Gastroenterology and Hepatology 2022; 13(3): 857 doi: 10.1016/j.jcmgh.2021.08.013
|
20 |
Ho Jung An, Mira A. Partha, HoJoon Lee, Billy T. Lau, Dmitri S. Pavlichin, Alison Almeda, Anna C. Hooker, Giwon Shin, Hanlee P. Ji. Tumor-associated microbiome features of metastatic colorectal cancer and clinical implications. Frontiers in Oncology 2024; 13 doi: 10.3389/fonc.2023.1310054
|
21 |
Ester Saus, Susana Iraola-Guzmán, Jesse R. Willis, Anna Brunet-Vega, Toni Gabaldón. Microbiome and colorectal cancer: Roles in carcinogenesis and clinical potential. Molecular Aspects of Medicine 2019; 69: 93 doi: 10.1016/j.mam.2019.05.001
|
22 |
Rozana Abdul Rahman, Angela Lamarca, Richard A. Hubner, Juan W. Valle, Mairéad G. McNamara. The Microbiome as a Potential Target for Therapeutic Manipulation in Pancreatic Cancer. Cancers 2021; 13(15): 3779 doi: 10.3390/cancers13153779
|
23 |
Hu Zhou, Yuan Yuan, Haorun Wang, Wei Xiang, Shenjie Li, Haowen Zheng, Yuqi Wen, Yang Ming, Ligang Chen, Jie Zhou. Gut Microbiota: A Potential Target for Cancer Interventions. Cancer Management and Research 2021; : 8281 doi: 10.2147/CMAR.S328249
|
24 |
Hourieh Sadrekarimi, Zhanna R. Gardanova, Morteza Bakhshesh, Farnoosh Ebrahimzadeh, Amirhossein Fakhre Yaseri, Lakshmi Thangavelu, Zahra Hasanpoor, Firoozeh Abolhasani Zadeh, Mohammad Saeed Kahrizi. Emerging role of human microbiome in cancer development and response to therapy: special focus on intestinal microflora. Journal of Translational Medicine 2022; 20(1) doi: 10.1186/s12967-022-03492-7
|
25 |
Mengfan Yue, Yu Tao, Yulai Fang, Xingpan Lian, Qin Zhang, Yufeng Xia, Zhifeng Wei, Yue Dai. The gut microbiota modulator berberine ameliorates collagen‐induced arthritis in rats by facilitating the generation of butyrate and adjusting the intestinal hypoxia and nitrate supply. The FASEB Journal 2019; 33(11): 12311 doi: 10.1096/fj.201900425RR
|
26 |
Ahmad Ali, Amina Mughal, Sharjeel Ahmad, Saira Abbas, Amer Mumtaz, Iftikhar Ahmed. Recent Advances and Future Perspectives of Microbial Metabolites. 2023; : 269 doi: 10.1016/B978-0-323-90113-0.00008-0
|
27 |
Eduardo Bueno Carneiro, Junio Cesar da Silva, Jonas Souza da Silva, Juliana Marcon Henke, Anderson Iacer Bueno. LITERATURE REVIEW OF THE MAIN MICROBIAL MARKERS FOR DIAGNOSIS OF COLORECTAL CANCER. Health and Society 2023; 3(03): 224 doi: 10.51249/hs.v3i03.1411
|
28 |
Hadi Feizi, Mohammad Ahangarzadeh Rezaee, Reza Ghotaslou, Mohammad Sadrkabir, Farhad Jadidi-Niaragh, Pourya Gholizadeh, Sepehr Taghizadeh, Khudaverdi Ghanbarov, Mehdi Yousefi, Hossein Samadi Kafil. Gut Microbiota and Colorectal Cancer Risk Factors. Current Pharmaceutical Biotechnology 2023; 24(8): 1018 doi: 10.2174/1389201023666221005103340
|
29 |
Jianing Yu, Lu Li, Xufeng Tao, Yanwei Chen, Deshi Dong. Metabolic interactions of host-gut microbiota: New possibilities for the precise diagnosis and therapeutic discovery of gastrointestinal cancer in the future—A review. Critical Reviews in Oncology/Hematology 2024; 203: 104480 doi: 10.1016/j.critrevonc.2024.104480
|
30 |
Prisca Gebrayel, Carole Nicco, Souhaila Al Khodor, Jaroslaw Bilinski, Elisabetta Caselli, Elena M. Comelli, Markus Egert, Cristina Giaroni, Tomasz M. Karpinski, Igor Loniewski, Agata Mulak, Julie Reygner, Paulina Samczuk, Matteo Serino, Mariusz Sikora, Annalisa Terranegra, Marcin Ufnal, Romain Villeger, Chantal Pichon, Peter Konturek, Marvin Edeas. Microbiota medicine: towards clinical revolution. Journal of Translational Medicine 2022; 20(1) doi: 10.1186/s12967-022-03296-9
|
31 |
Diagnostic and prognostic biomarkers in colorectal cancer and the potential role of exosomes in drug delivery. Cellular Signalling 2022; 99: 110413 doi: 10.1016/j.cellsig.2022.110413
|
32 |
M. F. Vecherkovskaya, G. V. Tetz, V. V. Tetz. Microbiota and cancer (review of literature). The Scientific Notes of the Pavlov University 2021; 27(4): 14 doi: 10.24884/1607-4181-2020-27-4-14-27
|
33 |
Soumya Pal, Adesh K. Saini, Ankur Kaushal, Shagun Gupta, Naseem A. Gaur, Anil K. Chhillar, Anil K. Sharma, Vijai K. Gupta, Reena V. Saini. The Colloquy between Microbiota and the Immune System in Colon Cancer:
Repercussions on the Cancer Therapy. Current Pharmaceutical Design 2022; 28(43): 3478 doi: 10.2174/1381612829666221122115906
|
34 |
Yuchen Liu, Yipin Yang, Xinyi Wang, Siyue Yin, Bingyu Liang, Yuchen Zhang, Min Fan, Ziyue Fu, Chuanlu Shen, Yanxun Han, Bangjie Chen, Qian Zhang. Function of microRNA‑124 in the pathogenesis of cancer (Review). International Journal of Oncology 2023; 64(1) doi: 10.3892/ijo.2023.5594
|
35 |
Karolina Kaźmierczak-Siedlecka, Agnieszka Daca, Mateusz Fic, Thierry van de Wetering, Marcin Folwarski, Wojciech Makarewicz. Therapeutic methods of gut microbiota modification in colorectal cancer management – fecal microbiota transplantation, prebiotics, probiotics, and synbiotics. Gut Microbes 2020; 11(6): 1518 doi: 10.1080/19490976.2020.1764309
|
36 |
Peng Xu, Zuo Tao, Hua Yang, Cheng Zhang. Obesity and early-onset colorectal cancer risk: emerging clinical evidence and biological mechanisms. Frontiers in Oncology 2024; 14 doi: 10.3389/fonc.2024.1366544
|
37 |
Eugeniy P. Smorodin. Prospects and Challenges of the Study of Anti-Glycan Antibodies and Microbiota for the Monitoring of Gastrointestinal Cancer. International Journal of Molecular Sciences 2021; 22(21): 11608 doi: 10.3390/ijms222111608
|
38 |
Timothy McAuliffe, Joseph C. Anderson, Robin J. Larson, Douglas J. Robertson. Systematic scoping review: Use of the faecal immunochemical test residual buffer to enhance colorectal cancer screening. Alimentary Pharmacology & Therapeutics 2024; 59(9): 1033 doi: 10.1111/apt.17947
|
39 |
Katie J. Stott, Bethan Phillips, Lee Parry, Stephanie May. Recent advancements in the exploitation of the gut microbiome in the diagnosis and treatment of colorectal cancer. Bioscience Reports 2021; 41(7) doi: 10.1042/BSR20204113
|
40 |
H. Liao, C. Li, Y. Ai, Y. Kou. Gut microbiome is more stable in males than in females during the development of colorectal cancer. Journal of Applied Microbiology 2021; 131(1): 435 doi: 10.1111/jam.14943
|
41 |
Ziyu Jiang, Lingchang Li, Jianan Chen, Guoli Wei, Yi Ji, Xi Chen, Jingbing Liu, Jiege Huo. Human gut-microbiome interplay: Analysis of clinical studies for the emerging roles of diagnostic microbiology in inflammation, oncogenesis and cancer management. Infection, Genetics and Evolution 2021; 93: 104946 doi: 10.1016/j.meegid.2021.104946
|
42 |
Ningning Zhang, Zeyu Wang, Jiayu Lv, Shuwen Zhang, Yang Liu, Tian Liu, Wang Li, Lan Gong, Xiaodong Zhang, Emad M. El-Omar, Wei Lu. Characterization of Gut Microbiota and Exploration of Potential Predictive Model for Hepatocellular Carcinoma Microvascular Invasion. Frontiers in Medicine 2022; 9 doi: 10.3389/fmed.2022.836369
|
43 |
Sona Ciernikova, Aneta Sevcikova, Beata Mladosievicova, Michal Mego. Microbiome in Cancer Development and Treatment. Microorganisms 2023; 12(1): 24 doi: 10.3390/microorganisms12010024
|
44 |
Natalia V. Beloborodova, Andrey V. Grechko, Andrey Yu Olenin. Metabolomics - New Insights into Biology and Medicine. 2020; doi: 10.5772/intechopen.87176
|
45 |
Carla Fiorentini, Francesca Carlini, Elena Angela Pia Germinario, Zaira Maroccia, Sara Travaglione, Alessia Fabbri. Gut Microbiota and Colon Cancer: A Role for Bacterial Protein Toxins?. International Journal of Molecular Sciences 2020; 21(17): 6201 doi: 10.3390/ijms21176201
|
46 |
Mahsa Mirzarazi, Soroor Bashiri, Ali Hashemi, Mahmoud Vahidi, Bahram Kazemi, Mojgan Bandehpour. The OmpA of commensal Escherichia coli of CRC patients affects apoptosis of the HCT116 colon cancer cell line. BMC Microbiology 2022; 22(1) doi: 10.1186/s12866-022-02540-y
|
47 |
Amir Hossein Mohseni, Sedigheh Taghinezhad-S, Xiangsheng Fu. Gut microbiota-derived metabolites and colorectal cancer: New insights and updates. Microbial Pathogenesis 2020; 149: 104569 doi: 10.1016/j.micpath.2020.104569
|
48 |
Jozef Kuzma, Dittmar Chmelař, Michal Hájek, Alexandra Lochmanová, Ivan Čižnár, Miroslav Rozložník, Miloslav Klugar. The role of intestinal microbiota in the pathogenesis of colorectal carcinoma. Folia Microbiologica 2020; 65(1): 17 doi: 10.1007/s12223-019-00706-2
|
49 |
A. B. Sagakyants. UNITED IMMUNOLOGICAL FORUM: CURRENT TRENDS IN THE DEVELOPMENT OF FUNDAMENTAL AND APPLIED ONCOIMMUNOLOGY (NOVOSIBIRSK, 2019). South Russian Journal of Cancer 2020; 1(2): 36 doi: 10.37748/2687-0533-2020-1-2-5
|
50 |
Zhongkun Zhou, Shiqiang Ge, Yang Li, Wantong Ma, Yuheng Liu, Shujian Hu, Rentao Zhang, Yunhao Ma, Kangjia Du, Ashikujaman Syed, Peng Chen. Human Gut Microbiome-Based Knowledgebase as a Biomarker Screening Tool to Improve the Predicted Probability for Colorectal Cancer. Frontiers in Microbiology 2020; 11 doi: 10.3389/fmicb.2020.596027
|
51 |
Océane C.B. Martin, Anna Bergonzini, Federica D'Amico, Puran Chen, Jerry W. Shay, Jacques Dupuy, Mattias Svensson, Maria G. Masucci, Teresa Frisan. Infection with genotoxin‐producingSalmonella entericasynergises with loss of the tumour suppressorAPCin promoting genomic instability via the PI3K pathway in colonic epithelial cells. Cellular Microbiology 2019; 21(12) doi: 10.1111/cmi.13099
|
52 |
Yesuf Adem Siraj, Melesse Gebeyehu Biadgelign, Mensur Osman Yassin, Yohannes Zenebe Chekol. Mucosa‐associated cultivable aerobic gut bacterial microbiota among colorectal cancer patients attending at the referral hospitals of Amhara Regional State, Ethiopia. Gut Pathogens 2021; 13(1) doi: 10.1186/s13099-021-00415-7
|
53 |
Ji Hyeong Song, Tae Jeong Oh, Sungwhan An, Kyung Ha Lee, Ji Yeon Kim, Jin Soo Kim. Comparative detection of syndecan-2 methylation in preoperative and postoperative stool DNA in patients with colorectal cancer. World Journal of Gastrointestinal Surgery 2023; 15(9): 2032-2041 doi: 10.4240/wjgs.v15.i9.2032
Abstract(304) |
Core Tip(305) |
Full Article(HTML)(1005)
|
Full Article with Cover (PDF)-1896K(65)
|
Full Article (Word)-476K(25)
|
Audio-365K(5)
|
Peer-Review Report-650K(41)
|
Answering Reviewers-143K(41)
|
Full Article (PDF)-1514K(93)
|
Full Article (XML)-87K(37)
|
Times Cited (1)
|
Total Visits (3397)
|
Open
|
54 |
Lan Zhao, Susan M Grimes, Stephanie U Greer, Matthew Kubit, HoJoon Lee, Lincoln D Nadauld, Hanlee P Ji. Characterization of the consensus mucosal microbiome of colorectal cancer. NAR Cancer 2021; 3(4) doi: 10.1093/narcan/zcab049
|
55 |
Francis K L Chan, Martin C S Wong, Andrew T Chan, James E East, Han-Mo Chiu, Govind K Makharia, David Weller, Choon Jin Ooi, Julajak Limsrivilai, Yutaka Saito, Dao V Hang, Jon D Emery, Dadang Makmun, Kaichun Wu, Raja Affendi Raja Ali, Siew C Ng. Joint Asian Pacific Association of Gastroenterology (APAGE)–Asian Pacific Society of Digestive Endoscopy (APSDE) clinical practice guidelines on the use of non-invasive biomarkers for diagnosis of colorectal neoplasia. Gut 2023; 72(7): 1240 doi: 10.1136/gutjnl-2023-329429
|
56 |
Edgar Torres-Maravilla, Anne-Sophie Boucard, Amir Hossein Mohseni, Sedigheh Taghinezhad-S, Naima G. Cortes-Perez, Luis G. Bermúdez-Humarán. Role of Gut Microbiota and Probiotics in Colorectal Cancer: Onset and Progression. Microorganisms 2021; 9(5): 1021 doi: 10.3390/microorganisms9051021
|
57 |
Maedeh Amini, Sama Rezasoltani, Hamid Asadzadeh Aghdaei, Mohamad Amin Pourhoseingholi, Mohammad Reza Zali. Accuracy of the Discriminatory Ability of Combined Fecal Microbiota Panel in the Early Detection of Patients with Colorectal Cancer. Journal of Gastrointestinal Cancer 2024; 55(1): 332 doi: 10.1007/s12029-023-00962-z
|
58 |
Simin Li, Mingxin He, Yumeng Lei, Yang Liu, Xinquan Li, Xiaochen Xiang, Qingming Wu, Qiang Wang. Oral Microbiota and Tumor—A New Perspective of Tumor Pathogenesis. Microorganisms 2022; 10(11): 2206 doi: 10.3390/microorganisms10112206
|
59 |
Hongwei Zhang, Mengmeng Lan, Guodong Cui, Weiming Zhu. The Influence of Caerulomycin A on the Intestinal Microbiota in SD Rats. Marine Drugs 2020; 18(5): 277 doi: 10.3390/md18050277
|
60 |
Qun Fang, Aijie Yang, Anshan Dong, Ligang Zhao. <p>circPDSS1 Stimulates the Development of Colorectal Cancer via Activating the Wnt/β-Catenin Signaling</p>. OncoTargets and Therapy 2020; : 6329 doi: 10.2147/OTT.S249853
|
61 |
Mark S. Johnstone, Gerard Lynch, James Park, Stephen McSorley, Joanne Edwards. Novel Methods of Risk Stratifying Patients for Metachronous, Pre-Malignant Colorectal Polyps: A Systematic Review. Critical Reviews in Oncology/Hematology 2021; 164: 103421 doi: 10.1016/j.critrevonc.2021.103421
|
62 |
Kevin D. Seely, Amanda D. Morgan, Lauren D. Hagenstein, Garrett M. Florey, James M. Small. Bacterial Involvement in Progression and Metastasis of Colorectal Neoplasia. Cancers 2022; 14(4): 1019 doi: 10.3390/cancers14041019
|
63 |
Poornima D. Vijendra, Pratap G. K., Kumar Vadlapudi, Manjula S.. Handbook of Research on Natural Products and Their Bioactive Compounds as Cancer Therapeutics. Advances in Medical Diagnosis, Treatment, and Care 2022; : 95 doi: 10.4018/978-1-7998-9258-8.ch005
|
64 |
Yuyi Li, Jinjin Peng, Xiangjun Meng. Gut bacteria, host immunity, and colorectal cancer: From pathogenesis to therapy. European Journal of Immunology 2024; doi: 10.1002/eji.202451022
|
65 |
Sheetal Kashyap, Soumya Pal, Gourav Chandan, Vipin Saini, Sasanka Chakrabarti, Neeraj K. Saini, Amit Mittal, Vijay Kumar Thakur, Adesh K. Saini, Reena V. Saini. Understanding the cross-talk between human microbiota and gastrointestinal cancer for developing potential diagnostic and prognostic biomarkers. Seminars in Cancer Biology 2022; 86: 643 doi: 10.1016/j.semcancer.2021.04.020
|
66 |
Shanshan Han, Min Lin, Lili Wu, Xuedan Lin, Meiyun Chen, Chuancai Hu, Anni Bao, Zejun Fang, Fengjiao Zhu. E2F1 modulates RCCD1 expression to participate in the initiation and progression of EMT in colorectal cancer. Pathology - Research and Practice 2024; 260: 155429 doi: 10.1016/j.prp.2024.155429
|
67 |
Vincenzo Arizza, Luca Vecchioni, Santo Caracappa, Giulia Sciurba, Flavia Berlinghieri, Antonino Gentile, Maria Flaminia Persichetti, Marco Arculeo, Rosa Alduina, Roberta Cimmaruta. New insights into the gut microbiome in loggerhead sea turtles Caretta caretta stranded on the Mediterranean coast. PLOS ONE 2019; 14(8): e0220329 doi: 10.1371/journal.pone.0220329
|
68 |
Murdani Abdullah, Ninik Sukartini, Saskia Aziza Nursyirwan, Rabbinu Rangga Pribadi, Hasan Maulahela, Amanda Pitarini Utari, Virly Nanda Muzellina, Agustinus Wiraatmadja, Kaka Renaldi. Gut Microbiota Profiles in Early- and Late-Onset Colorectal Cancer: A Potential Diagnostic Biomarker in the Future. Digestion 2021; 102(6): 823 doi: 10.1159/000516689
|
69 |
Tayebe Shahbazi, Bita Bakhshi, Mohammad Sadegh Fazeli, Elahe Derakhshan-Nezhadc. Bacterial biomarkers: new aspects of colorectal tumors diagnosis: reality or fantasy. European Journal of Cancer Prevention 2023; 32(5): 485 doi: 10.1097/CEJ.0000000000000760
|
70 |
Ishfaq Ahmed, Shahid Umar. Microbiome and Colorectal Cancer. Current Colorectal Cancer Reports 2018; 14(6): 217 doi: 10.1007/s11888-018-0416-7
|
71 |
Jianyi Wang, Chuhan Wang, Le Li, Lirui Yang, Shuoshuo Wang, Xuelian Ning, Shuangshu Gao, Lili Ren, Anita Chaulagain, Jing Tang, Tianzhen Wang. Alternative splicing: An important regulatory mechanism in colorectal carcinoma. Molecular Carcinogenesis 2021; 60(4): 279 doi: 10.1002/mc.23291
|
72 |
Arghya Kusum Dhar. Synbiotics for the Management of Cancer. 2023; : 205 doi: 10.1007/978-981-19-7550-9_10
|
73 |
Marco Vacante, Roberto Ciuni, Francesco Basile, Antonio Biondi. Gut Microbiota and Colorectal Cancer Development: A Closer Look to the Adenoma-Carcinoma Sequence. Biomedicines 2020; 8(11): 489 doi: 10.3390/biomedicines8110489
|
74 |
Suleiman Zakari, Nguedia K. Niels, Grace V. Olagunju, Precious C. Nnaji, Oluwabusayo Ogunniyi, Mercy Tebamifor, Emmanuel N. Israel, Sunday E. Atawodi, Olubanke Olujoke Ogunlana. Emerging biomarkers for non-invasive diagnosis and treatment of cancer: a systematic review. Frontiers in Oncology 2024; 14 doi: 10.3389/fonc.2024.1405267
|
75 |
Anqi Chen, Zhengting Jiang, Lingli Cai, Dong Tang. On the road to colorectal cancer development: crosstalk between the gut microbiota, metabolic reprogramming, and epigenetic modifications. Carcinogenesis 2023; 44(8-9): 631 doi: 10.1093/carcin/bgad058
|
76 |
Hui Zhao, Man He, Meng Zhang, Qiang Sun, Sha Zeng, Li Chen, Han Yang, Maolun Liu, Shan Ren, Xianli Meng, Haibo Xu. Colorectal Cancer, Gut Microbiota and Traditional Chinese Medicine: A Systematic Review. The American Journal of Chinese Medicine 2021; 49(04): 805 doi: 10.1142/S0192415X21500385
|
77 |
Jia-Yi Su, Yun Wang, Shang-Shang Wu, Wen-Kun Li, Cheng-Yao Wang, Jiu-Yue Ma, Yu-Ting Qiu, Min-Si Zhou, Zhan Wang, Peng Li, Chun-Tao Liu, Jing Wu. Association between new plasma inflammatory markers and risk of colorectal neoplasms in individuals over 50 years old. Carcinogenesis 2023; 44(12): 824 doi: 10.1093/carcin/bgad064
|
78 |
Vandna Singh, Shruti Ahlawat, Hari Mohan, Sarvajeet Singh Gill, Krishna Kant Sharma. Balancing reactive oxygen species generation by rebooting gut microbiota. Journal of Applied Microbiology 2022; 132(6): 4112 doi: 10.1111/jam.15504
|
79 |
Mehul R. Chorawala, Humzah Postwala, Bhupendra G. Prajapati, Yesha Shah, Aayushi Shah, Aanshi Pandya, Nirjari Kothari. Colorectal Cancer. 2024; : 29 doi: 10.1016/B978-0-443-13870-6.00021-0
|
80 |
Ran Meng, Minmin Zeng, Ying Ji, Xinxiang Huang, Min Xu. The potential role of gut microbiota outer membrane vesicles in colorectal cancer. Frontiers in Microbiology 2023; 14 doi: 10.3389/fmicb.2023.1270158
|
81 |
Siti Maryam Ahmad Kendong, Raja Affendi Raja Ali, Khairul Najmi Muhammad Nawawi, Hajar Fauzan Ahmad, Norfilza Mohd Mokhtar. Gut Dysbiosis and Intestinal Barrier Dysfunction: Potential Explanation for Early-Onset Colorectal Cancer. Frontiers in Cellular and Infection Microbiology 2021; 11 doi: 10.3389/fcimb.2021.744606
|
82 |
Lan Zhao, William C. Cho, Mark R. Nicolls. Colorectal Cancer-Associated Microbiome Patterns and Signatures. Frontiers in Genetics 2021; 12 doi: 10.3389/fgene.2021.787176
|
83 |
Liang Yu, Juan Lu. Long non-coding RNA, FOXP4-AS1, acts as a novel biomarker of cancers. Oncologie 2023; 25(6): 619 doi: 10.1515/oncologie-2023-0295
|
84 |
Romain Villéger, Amélie Lopès, Guillaume Carrier, Julie Veziant, Elisabeth Billard, Nicolas Barnich, Johan Gagnière, Emilie Vazeille, Mathilde Bonnet. Intestinal Microbiota: A Novel Target to Improve Anti-Tumor Treatment?. International Journal of Molecular Sciences 2019; 20(18): 4584 doi: 10.3390/ijms20184584
|
85 |
Noor Alrushaid, Firdos Alam Khan, Ebtesam Al-Suhaimi, Abdelhamid Elaissari. Progress and Perspectives in Colon Cancer Pathology, Diagnosis, and Treatments. Diseases 2023; 11(4): 148 doi: 10.3390/diseases11040148
|